Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Propranolol hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Propranolol 40mg tablets
0204000R0AAAJAJ
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 375,149 |
|
Propranolol 10mg tablets
0204000R0AAAHAH
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 240,421 |
|
Propranolol 80mg modified-release capsules
0204000R0AAAAAA
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 234,909 |
|
Propranolol 160mg modified-release capsules
0204000R0AAABAB
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 72,875 |
|
Propranolol 80mg tablets
0204000R0AAAKAK
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 47,905 |
|
Propranolol 10mg/5ml oral solution sugar free
0204000R0AACXCX
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 4,084 |
|
Propranolol 5mg/5ml oral solution sugar free
0204000R0AACWCW
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 3,145 |
|
Propranolol 40mg/5ml oral solution sugar free
0204000R0AADBDB
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 2,777 |
|
Half Beta-Prograne 80mg modified-release capsules (Tillomed)
0204000R0BNABAA
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 2,717 |
|
Bedranol SR 80mg capsules (Sandoz)
0204000R0BDADAA
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 2,381 |
|
Propranolol 160mg tablets
0204000R0AAALAL
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 1,794 |
|
Propranolol 50mg/5ml oral solution sugar free
0204000R0AACYCY
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 1,682 |
|
Bedranol SR 80mg capsules (Almus)
0204000R0BDAFAA
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 612 |
|
Bedranol SR 160mg capsules (Sandoz)
0204000R0BDACAB
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 473 |
|
Beta-Prograne 160mg modified-release capsules (Tillomed)
0204000R0BNAAAB
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 345 |
|
Half Beta-Prograne 80mg modified-release capsules (Accord)
0204000R0BNAEAA
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 228 |
|
Half Beta-Prograne 80mg modified-release capsules (Teva)
0204000R0BNADAA
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 224 |
|
Bedranol SR 160mg capsules (Almus)
0204000R0BDAEAB
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 59 |
|
Beta-Prograne 160mg modified-release capsules (Teva)
0204000R0BNACAB
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 39 |
|
Beta-Prograne 160mg modified-release capsules (Actavis)
0204000R0BNAFAB
|
Beta-Prograne | Propranolol hydrochloride | Cardiovascular System | 36 |
|
Half Inderal LA 80mg capsules
0204000R0BGAFAA
|
Inderal | Propranolol hydrochloride | Cardiovascular System | 35 |
|
Bedranol 40mg tablets
0204000R0BDAIAJ
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 34 |
|
Bedranol 80mg tablets
0204000R0BDAJAK
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 9 |
|
Propranolol 10mg/5ml oral liquid
0204000R0AACJCJ
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 9 |
|
Bedranol 10mg tablets
0204000R0BDAGAH
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 5 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.